<doi_batch xmlns="http://www.crossref.org/schema/4.4.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="4.4.0"><head><doi_batch_id>bfdb4989-cec6-47ae-956b-eb5e1ba1879f</doi_batch_id><timestamp>20250729065059889</timestamp><depositor><depositor_name>wseas:wseas</depositor_name><email_address>mdt@crossref.org</email_address></depositor><registrant>MDT Deposit</registrant></head><body><journal><journal_metadata language="en"><full_title>WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE</full_title><issn media_type="electronic">2224-2902</issn><issn media_type="print">1109-9518</issn><archive_locations><archive name="Portico"/></archive_locations><doi_data><doi>10.37394/23208</doi><resource>http://wseas.org/wseas/cms.action?id=4011</resource></doi_data></journal_metadata><journal_issue><publication_date media_type="online"><month>1</month><day>7</day><year>2025</year></publication_date><publication_date media_type="print"><month>1</month><day>7</day><year>2025</year></publication_date><journal_volume><volume>22</volume><doi_data><doi>10.37394/23208.2025.22</doi><resource>https://wseas.com/journals/bab/2025.php</resource></doi_data></journal_volume></journal_issue><journal_article language="en"><titles><title>Blood Groups and Living Donor Liver Transplantation in Georgia</title></titles><contributors><person_name sequence="first" contributor_role="author"><given_name>Marika</given_name><surname>Mortuladze</surname><affiliation>Faculty of Natural Sciences and Health Care, Batumi Shota Rustaveli State University, St.35/32 Ninoshvili/Rustaveli, Batumi, Adjara, GEORGIA</affiliation></person_name><person_name sequence="additional" contributor_role="author"><given_name>George</given_name><surname>Kamkamidze</surname><affiliation>The School of Health Sciences, University of Georgia, St.Merab Kostava 77, Tbilisi, GEORGIA</affiliation></person_name><person_name sequence="additional" contributor_role="author"><given_name>Sophio</given_name><surname>Beridze</surname><affiliation>Faculty of Natural Sciences and Health Care, Batumi Shota Rustaveli State University, St.35/32 Ninoshvili/Rustaveli, Batumi, Adjara, GEORGIA</affiliation></person_name><person_name sequence="additional" contributor_role="author"><given_name>Kakhaber</given_name><surname>Kashibadze</surname><affiliation>Faculty of Natural Sciences and Health Care, Batumi Shota Rustaveli State University, St.35/32 Ninoshvili/Rustaveli, Batumi, Adjara, GEORGIA</affiliation></person_name><person_name sequence="additional" contributor_role="author"><given_name>Marina</given_name><surname>Nagervadze</surname><affiliation>Faculty of Natural Sciences and Health Care, Batumi Shota Rustaveli State University, St.35/32 Ninoshvili/Rustaveli, Batumi, Adjara, GEORGIA</affiliation></person_name></contributors><jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1"><jats:p>The need for liver transplantation is increasing as mortality from liver disease is rising and outcomes after transplant are excellent liver transplantation evolved to become a viable treatment option for end-stage liver disease and nowadays it is the great story of success of modern surgery and medicine. To find a potential association of blood groups (ABO and Rh) with complications of liver diseases and the need for transplantation, as well as its possible association with post-transplant survival rates across the region. Information on variables of interest was obtained from the medical documentation of patients’ medical cards at the Batumi Referral Hospital (Georgia) from December 2014 to July 2024, a total of 103 patients. The Study subjects were liver recipients who had living donor liver transplantation and were analyzed by chi-square. ABO and Rh blood groups in the studied recipients demonstrate that more than half of recipients (55.6±5.0%) have the O (I) Rh+ phenotype, followed by the O (I) Rh- phenotype in 5.2±2.2% (n=5), or 34±4.8% A (II) Rh+ phenotype is present in % (n=33), A (II) Rh- phenotype is present in 2.1±1.5% (n=2), B (III) Rh+ phenotype is present in 2.1±1.5% (n=2), and B (III) Rh-phenotype occurs only in one recipient. Our research showed the interesting and statistically significant distribution of Blood groups among recipients, Donors, and Healthy controls. A limitation of our study is the small number of the studied recipients, which did not allow us to see the phenotype of group B in the mentioned category.</jats:p></jats:abstract><publication_date media_type="online"><month>7</month><day>29</day><year>2025</year></publication_date><publication_date media_type="print"><month>7</month><day>29</day><year>2025</year></publication_date><pages><first_page>389</first_page><last_page>399</last_page></pages><publisher_item><item_number item_number_type="article_number">36</item_number></publisher_item><ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators"><ai:free_to_read start_date="2025-07-29"/><ai:license_ref applies_to="am" start_date="2025-07-29">https://wseas.com/journals/bab/2025/a725108-264.pdf</ai:license_ref></ai:program><archive_locations><archive name="Portico"/></archive_locations><doi_data><doi>10.37394/23208.2025.22.36</doi><resource>https://wseas.com/journals/bab/2025/a725108-264.pdf</resource></doi_data><citation_list><citation key="ref0"><doi>10.5500/wjt.v10.i9.256</doi><unstructured_citation>D. Mikulic and A. Mrzljak, “Liver transplantation and aging,” WJT, vol. 10, no. 9, pp. 256–266, Sep. 2020, doi: 10.5500/wjt.v10.i9.256. </unstructured_citation></citation><citation key="ref1"><doi>10.1007/s11901-020-00527-9</doi><unstructured_citation>N. Mahmud, “Selection for Liver Transplantation: Indications and Evaluation,” Curr Hepatology Rep, vol. 19, no. 3, pp. 203– 212, Sep. 2020, doi: 10.1007/s11901-020- 00527-9. </unstructured_citation></citation><citation key="ref2"><doi>10.1016/s0168-8278(03)00009-6</doi><unstructured_citation>D. C. Broering, M. Sterneck, X. Rogiers. “Living donor liver transplantation", Journal of Hepatology”, Vol.38, Supplement 1119- 1352003. </unstructured_citation></citation><citation key="ref3"><unstructured_citation>S. Nadalin et al., “Living donor liver transplantation in Europe,” Hepatobiliary Surgery and Nutrition, vol. 5, no. 2, Art. no. 2, Apr. 2016, doi: 10.3978/j.issn.2304- 3881.2015.10.04. </unstructured_citation></citation><citation key="ref4"><doi>10.1016/b978-0-323-99655-6.00007-5</doi><unstructured_citation>R. I. Troisi, G. Cassese, and B. De Hemptinne, “Living donation in liver transplantation: Overview of history, indications, and specific aspects of living donation in liver transplantation,” in The Liver Graft Before Transplantation, Elsevier, 2024, pp. 45–67. doi: 10.1016/B978-0-323-99655-6.00007-5. </unstructured_citation></citation><citation key="ref5"><doi>10.1016/j.jss.2022.05.026</doi><unstructured_citation>A. D. Tevar et al., “Back Table Preparation of the Right Lobe Live Donor Liver Allograft: A Crucial Part of the Adult Live Donor Liver Transplant Procedure,” Journal of Surgical Research, vol. 279, pp. 796–802, Nov. 2022, doi: 10.1016/j.jss.2022.05.026. </unstructured_citation></citation><citation key="ref6"><doi>10.1046/j.1365-3148.2001.00313.x</doi><unstructured_citation>L. Rydberg, “ABO‐ incompatibility in solid organ transplantation,” Transfusion Medicine, vol. 11, no. 4, pp. 325–342, Aug. 2001, doi: 10.1046/j.1365-3148.2001.00313.x. </unstructured_citation></citation><citation key="ref7"><doi>10.15761/ccrr.1000221</doi><unstructured_citation>N. Kawagishi and S. Satomi, “Current aspects of ABO-incompatible liver transplantation,” Clin Case Rep Rev, vol. 2, no. 4, 2016, doi: 10.15761/CCRR.1000221. </unstructured_citation></citation><citation key="ref8"><unstructured_citation>R. D. Gordon et al., “Experience with primary liver transplantation across ABO blood groups,” Transplant Proc, vol. 19, no. 6, pp. 4575–4579, Dec. 1987. </unstructured_citation></citation><citation key="ref9"><doi>10.1097/tp.0000000000004289</doi><unstructured_citation>M. Kanneganti, K. M. Olthoff, and T. Bittermann, “Impact of Older Donor Age on Recipient and Graft Survival after LDLT: The US Experience,” Transplantation, vol. 107, no. 1, pp. 162–171, Jan. 2023, doi: 10.1097/TP.0000000000004289. </unstructured_citation></citation><citation key="ref10"><doi>10.1155/2021/6629060</doi><unstructured_citation>S. B. Abegaz, “Human ABO Blood Groups and Their Associations with Different Diseases,” BioMed Research International, vol. 2021, pp. 1–9, Jan. 2021, doi: 10.1155/2021/6629060. </unstructured_citation></citation><citation key="ref11"><doi>10.1186/s12889-019-6784-3</doi><unstructured_citation>L. M. Hagan et al., “Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination,” BMC Public Health, vol. 19, no. S3, p. 480, May 2019, doi: 10.1186/s12889-019-6784-3. </unstructured_citation></citation><citation key="ref12"><doi>10.1016/j.vaccine.2023.04.051</doi><unstructured_citation>A. Berry, D. Kapelus, P. Singh, M. Groome, and D. De Assis Rosa, “ABO blood types, but not Secretor or Lewis blood types, influence strength of antibody response to Hepatitis B vaccine in Black South African children,” Vaccine, vol. 41, no. 24, pp. 3617–3626, Jun. 2023, doi: 10.1016/j.vaccine.2023.04.051. </unstructured_citation></citation><citation key="ref13"><doi>10.32007/jfacmedbagdad.541771</doi><unstructured_citation>O. A. A. Aljooani, N. N. Al-Hayani, and M. J. Mohammed, “The infection with HBV and HCV and their relationship to ABO blood group among blood donors,” JFacMedBagdad, vol. 54, no. 1, pp. 52–56, Apr. 2012, doi: 10.32007/jfacmedbagdad.541771. </unstructured_citation></citation><citation key="ref14"><unstructured_citation>T. Wu et al., “ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy,” Sci Rep, vol. 7, no. 1, p. 4412, Jun. 2017, doi: 10.1038/s41598-017-04046-4. </unstructured_citation></citation><citation key="ref15"><doi>10.1371/journal.pone.0225792</doi><unstructured_citation>G.-C. Zhong et al., “ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population,” PLoS ONE, vol. 14, no. 12, p. e0225792, Dec. 2019, doi: 10.1371/journal.pone.0225792. </unstructured_citation></citation><citation key="ref16"><doi>10.1007/s12288-019-01197-4</doi><unstructured_citation>I. Tsintsadze et al., “Specific Combinations of Erythrocyte Group Antigens in Blood Donors,” Indian J Hematol Blood Transfus, vol. 36, no. 2, pp. 356–360, Apr. 2020, doi: 10.1007/s12288-019-01197-4. </unstructured_citation></citation><citation key="ref17"><unstructured_citation>M. Nagervadze et al., “ABO system combination with Rh, Kell and MN group in Georgian blood donors,” Am J Blood Res, vol. 11, no. 2, pp. 132–139, 2021. </unstructured_citation></citation><citation key="ref18"><unstructured_citation>“Chi Square Calculator - Up To 5x5, With Steps,” Social Science Statistics, [Online]. https://www.socscistatistics.com/tests/chisquar e2/default2.aspx (Accessed Date: November 17, 2024). </unstructured_citation></citation><citation key="ref19"><unstructured_citation>“On Human Organ Transplants" - LEPL "Georgian Legislative Herald" (სსიპ ”საქართველოს საკანონმდებლო მაცნე), [Online]. https://matsne.gov.ge/en/document/view/1678 0?publication=10 (Accessed Date: December 21, 2024). </unstructured_citation></citation><citation key="ref20"><doi>10.1002/lt.22002</doi><unstructured_citation>H. C. Hermann, B. F. Klapp, G. Danzer, and C. Papachristou, “Gender-specific differences associated with living donor liver transplantation: A review study,” Liver Transpl, vol. 16, no. 3, pp. 375–386, Mar. 2010, doi: 10.1002/lt.22002. </unstructured_citation></citation><citation key="ref21"><doi>10.3390/ijerph15010170</doi><unstructured_citation>J. Yang, Y. Zhang, L. Luo, R. Meng, and C. Yu, “Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis,” IJERPH, vol. 15, no. 1, p. 170, Jan. 2018, doi: 10.3390/ijerph15010170. </unstructured_citation></citation><citation key="ref22"><doi>10.1111/ctr.15099</doi><unstructured_citation>T. Robinson, P. A. Vargas, J. Oberholzer, S. Pelletier, and N. Goldaracena, “Survival after LDLT in recipients ≥70 years old in the United States. An OPTN/UNOS liver transplant registry analysis,” Clinical Transplantation, vol. 37, no. 11, p. e15099, Nov. 2023, doi: 10.1111/ctr.15099. </unstructured_citation></citation><citation key="ref23"><unstructured_citation>Human Blood Groups (Группы крови человека)”, [Online]. Available: https://studfile.net/preview/21484365/page:43/ (Accessed Date: May 2, 2025). </unstructured_citation></citation><citation key="ref24"><unstructured_citation>“Living donor liver transplantation in adults - UpToDate”, [Online]. https://www.uptodate.com/contents/livingdonor-liver-transplantation-in-adults/print (Accessed Date: September 21, 2025).</unstructured_citation></citation></citation_list></journal_article></journal></body></doi_batch>